Attached files
file | filename |
---|---|
S-1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_s1.htm |
EX-10.7 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-7.htm |
EX-10.8 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-8.htm |
EX-21.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex21-1.htm |
EX-23.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex23-1.htm |
EX-10.5 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-5.htm |
Exhibit
10.6
SHELL
COMPANY PURCHASE AGREEMENT
THIS
SHELL COMPANY PURCHASE AGREEMENT (this “Agreement”), is dated as of Dec.8, 2007,
by and between Sinary Bio-Technology Holdings Group, Inc. (Party
A) and Wangyin,CEO of Weikang (Party B)
WHEREAS, the share exchange
agreement between Party A and EXDG.OB as of Dec.7,2007. Party A should pay
650,000 US dollar.
AGREEMENT:
NOW, THEREFORE, in
consideration of the mutual covenants and other agreements contained in this
Agreement, both parties hereby agree as follows:
1、
|
The
payment of $650,000 will made by Mr.Wangyin,CEO of Heilongjiang Weikang on
behalf of Sinary in connection with the reverse acquisition on
December 7, 2007.
|
2、
|
Part
B will remit the fee to the account the investment bank offered when the
agreement is in effective.
|
3、
|
Payment: All payment
is made in US dollar.
|
4、
|
The
agreement shall become effective as of the day when the Assignor and the
Assignee have affixed their signatures on it.
|
Part
A:Signature
of Wangweili CEO of Sinary
Part
B:Signature
of Wangyin CEO of Weikang